Skip to main content

Day: September 20, 2023

Kayne Anderson Energy Infrastructure Fund Announces Distribution of $0.21 per Share for Q3 2023

HOUSTON, Sept. 20, 2023 (GLOBE NEWSWIRE) — Kayne Anderson Energy Infrastructure Fund, Inc. (the “Company”) (NYSE: KYN) announced today a quarterly distribution of $0.21 per share for the fiscal quarter ended August 31, 2023. This distribution is payable to common stockholders on October 10, 2023 (as outlined in the table below).Ex-Date Record Date Payment Date DistributionAmount Return of CapitalEstimate(1)         9/29/23 10/2/23 10/10/23 $0.21 10%         (1)  This estimate is based on the Company’s anticipated earnings and profits. The final determination of the tax character of distributions will not be determinable until after the end of the fiscal year and may differ substantially from this preliminary information. Kayne Anderson Energy Infrastructure Fund, Inc. (NYSE: KYN) is a non-diversified, closed-end...

Continue reading

Broad Capital Acquisition Corp Confirms Funding to Extend Period to Consummate Initial Business Combination to October 13, 2023

Dallas, Texas, Sept. 20, 2023 (GLOBE NEWSWIRE) — Broad Capital Acquisition Corp. (the “Company”) (NASDAQ: BRAC, BRACR, BRACU), a special purpose acquisition company formed by Broad Capital LLC, today announced that on September 19, 2023 it caused to be deposited $150,000 (the “Extension Payment”) into the Company’s trust account for its public stockholders, representing $0.0332 per public share, allowing the Company to extend the period of time it has to consummate its initial business combination to October 13, 2023 (the “Monthly Extension”). The Monthly Extension is the ninth of the twelve monthly extensions permitted under the Company’s governing documents. Business Combination On January 18, 2023, the Company entered into a definitive Agreement and Plan of Merger and Business Combination Agreement (the “Business Combination...

Continue reading

Hawthorn Bancshares, Inc. Names New Chief Financial Officer

JEFFERSON CITY, Mo., Sept. 20, 2023 (GLOBE NEWSWIRE) — Hawthorn Bancshares, Inc. (NASDAQ: HWBK) and its subsidiary Hawthorn Bank announced today that Christopher Hafner will be named Senior Vice President and Chief Financial Officer of both entities effective October 13, 2023, replacing Steve Guthrie who retired from the position on September 1, 2023. A 34-year industry veteran, Hafner has previously held the roles of Chief Accounting Officer at CrossFirst Bank, Chief Financial Officer at each of Missouri Bank and First National Bank of Kansas, Assistant Controller at Commerce Bancshares, Inc. and also previously served in various roles in the audit practice of a public accounting firm. “I am delighted to welcome Chris to the executive team and I’m confident he will play an important role in the future success of our company,”...

Continue reading

CVB Financial Corp. Announces 136th Consecutive Cash Dividend

ONTARIO, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) — CVB Financial Corp. (NASDAQ: CVBF) (the “Company”) announced a twenty cent ($0.20) per share cash dividend with respect to the third quarter of 2023.  This dividend was approved at the Company’s regularly scheduled Board of Directors meeting held on September 20, 2023. The quarterly dividend will be payable on or about October 19, 2023 to shareholders of record as of October 4, 2023. “We are pleased to announce our 136th consecutive cash dividend paid to our shareholders,” said David A. Brager, President and Chief Executive Officer. Corporate Overview CVB Financial Corp. (“CVBF”) is the holding company for Citizens Business Bank. CVBF is one of the 10 largest bank holding companies headquartered in California with over $16 billion in total assets. Citizens Business Bank is consistently...

Continue reading

Borqs Technologies Receives Nasdaq Notification Regarding Minimum Market Value Deficiency

SANTA CLARA, Calif., Sept. 20, 2023 (GLOBE NEWSWIRE) — Borqs Technologies, Inc. (Nasdaq: BRQS, “Borqs”, or the “Company”), a global provider of 5G wireless and Internet of Things (IoT) solutions, today announced that the Company received a deficiency notification letter from the Nasdaq Stock Market LLC (“Nasdaq”) on September 15, 2023, notifying the Company that the Company’s listed securities did not maintain a minimum market value of $35 million (“MVLS”) for a period of 30 consecutive business days to meet the MVLS requirement. In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company has been provided a compliance period of 180 calendar days, or until March 13, 2024, to regain compliance. Nasdaq will close the matter and provide written confirmation that the Company has achieved compliance with rule 5550(b)(2) if at...

Continue reading

Gaming and Leisure Properties, Inc. Mourns the Loss of Board Member JoAnne A. Epps

WYOMISSING, Pa., Sept. 20, 2023 (GLOBE NEWSWIRE) — Gaming and Leisure Properties, Inc. (NASDAQ: GLPI) – mourns the loss of board member, JoAnne A. Epps, who passed away suddenly on Tuesday, September 19th. JoAnne joined the Board of Directors in September 2021, providing invaluable counsel to the management team throughout her tenure as a Board member. She was serving as Acting President of Temple University at the time of her passing and spent nearly 40 years serving the university and its community. Gaming and Leisure Properties Chairman and Chief Executive Officer, Peter M. Carlino, stated, “We are deeply saddened by the passing of our friend and fellow board member, JoAnne Epps. It was a privilege for me and my fellow Board members to have worked alongside JoAnne. We will be forever grateful for her dedication and service...

Continue reading

Disc Medicine Receives FDA Fast Track Designation for MWTX-003 for the Treatment of Polycythemia Vera

WATERTOWN, Mass., Sept. 20, 2023 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases, today announced that the United States Food and Drug Administration (FDA) has granted Fast Track Designation to MWTX-003 for the treatment of patients with polycythemia vera (PV). “We are delighted to have received Fast Track designation for MWTX-003, which highlights the unmet need for PV patients and the potential of MWTX-003 in a disease where there are few treatment options,” said John Quisel, J.D., Ph.D., President and Chief Executive Officer of Disc. “We believe MWTX-003 is uniquely positioned to address the needs of PV patients and are excited to initiate a...

Continue reading

ORIC Pharmaceuticals to Participate in the 2023 Cantor Global Healthcare Conference

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Sept. 20, 2023 (GLOBE NEWSWIRE) — ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in a fireside chat at the 2023 Cantor Global Healthcare Conference on Thursday, September 28, 2023, at 8:00 a.m. ET. A live webcast of the discussion will be available through the investor section of the company’s website at www.oricpharma.com. Replays of the webcast will be available for 90 days following the events. About ORIC Pharmaceuticals, Inc. ORIC Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to improving patients’ lives by Overcoming Resistance In Cancer. ORIC’s clinical stage product candidates include (1) ORIC-114,...

Continue reading

Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults

Full commercial launch of NexoBrid marks important first step to becoming the new standard of care for eschar removal in patients with deep partial- and/or full- thickness thermal burns NexoBrid launch significantly expands the total addressable market for Vericel Burn Care CAMBRIDGE, Mass., Sept. 20, 2023 (GLOBE NEWSWIRE) — Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the U.S. commercial availability of NexoBrid® (anacaulase-bcdb) for the removal of eschar in adults with deep partial- and/or full-thickness thermal burns. Eschar removal is a critical first step in the treatment of burns as it can reduce inflammation, stop burn progression, as well as mitigate infections and sepsis. Surgical excision, which is the current standard of care...

Continue reading

Clover Health to Host Virtual Clover Assistant Showcase on October 12, 2023

FRANKLIN, Tenn., Sept. 20, 2023 (GLOBE NEWSWIRE) — Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover,” “Clover Health” or the “Company”), a physician enablement company committed to bringing access to great healthcare to everyone on Medicare, today announced that it will host a virtual Clover Assistant Showcase on Thursday, October 12, 2023 at 12:00 p.m. Eastern Time. The event will feature informative product demonstrations, followed by a live Q&A session with Clover executives and key members of the Clover Assistant team. “Healthcare is at a pivotal moment, and Clover Assistant is our answer to the challenges we face,” said Andrew Toy, Chief Executive Officer of Clover Health. “Software-assisted doctors focusing on the early detection of disease aren’t just a nice-to-have; they’re critical....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.